Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells

Journal Article · · Scientific Reports
DOI:https://doi.org/10.1038/srep14633· OSTI ID:1624799
 [1];  [2];  [3];  [2];  [4];  [2];  [4];  [2];  [4]
  1. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicological Research. Division of Genetic and Molecular Toxicology; DOE/OSTI
  2. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicological Research. Division of Biochemical Toxicology
  3. Chongqing Univ. (China). College Bioengineering
  4. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicological Research. Division of Genetic and Molecular Toxicology
Ginkgo biloba leaf extract has been shown to increase the incidence in liver tumors in mice in a 2-year bioassay conducted by the National Toxicology Program. In this study, the DNA damaging effects of Ginkgo biloba leaf extract and many of its constituents were evaluated in human hepatic HepG2 cells and the underlying mechanism was determined. A molecular docking study revealed that quercetin, a flavonoid constituent of Ginkgo biloba, showed a higher potential to interact with topoisomerase II (Topo II) than did the other Ginkgo biloba constituents; this in silico prediction was confirmed by using a biochemical assay to study Topo II enzyme inhibition. Moreover, as measured by the Comet assay and the induction of γ-H2A.X, quercetin, followed by keampferol and isorhamnetin, appeared to be the most potent DNA damage inducer in HepG2 cells. In Topo II knockdown cells, DNA damage triggered by Ginkgo biloba leaf extract or quercetin was dramatically decreased, indicating that DNA damage is directly associated with Topo II. DNA damage was also observed when cells were treated with commercially available Ginkgo biloba extract product. Our findings suggest that Ginkgo biloba leaf extract- and quercetin-induced in vitro genotoxicity may be the result of Topo II inhibition.
Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
SC0014664
OSTI ID:
1624799
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 5; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (58)

A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings: GINKGO BILOBA journal July 2002
Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group journal November 1996
HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved journal February 2013
Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects journal February 2010
Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers journal December 2011
An Overview of DNA and RNA Bindings to Antioxidant Flavonoids journal June 2007
Activity of the plant flavanol quercetin in the mouse lymphoma L5178Y TK+/− mutation, DNA single-strand break, and Balb/c 3T3 chemical transformation assays journal March 1981
Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals journal March 2009
Acupressure and Postoperative Vomiting, Soy and Breast Cancer, Gingko Biloba and Alzheimer's Disease, Acupuncture and Irritable Bowel Syndrome, Mediterranean and Low-Carbohydrate Diets journal March 2013
Herb–drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats journal December 2007
Assessment of DNA damage, cytotoxicity, and apoptosis in human hepatoma (HepG2) cells after flurochloridone herbicide exposure journal March 2014
Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters journal October 2011
DNA topoisomerase II, genotoxicity, and cancer journal October 2007
Genotoxicity of topoisomerase II inhibitors: An anti-infective perspective journal December 2008
Sertraline induces endoplasmic reticulum stress in hepatic cells journal August 2014
Mechanism study of goldenseal-associated DNA damage journal July 2013
Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens journal May 1998
Catalytic topoisomerase II inhibitors in cancer therapy journal August 2003
Genotoxicity of several clinically used topoisomerase II inhibitors journal July 2000
Chk1 and Chk2 kinases in checkpoint control and cancer journal May 2003
Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity journal December 2004
Plasma Levels and Distribution of Flavonoids in Rat Brain after Single and Repeated Doses of Standardized Ginkgo biloba Extract EGb 761® journal May 2010
DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139 journal March 1998
Caffeic acid and quercitrin purified from Houttuynia cordata inhibit DNA topoisomerase I activity journal February 2011
Advantages of Human Hepatocyte-Derived Transformants Expressing a Series of Human Cytochrome P450 Isoforms for Genotoxicity Examination journal May 2010
Methysticin and 7,8-Dihydromethysticin are Two Major Kavalactones in Kava Extract to Induce CYP1A1 journal September 2011
Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent journal March 2012
Sertraline, an Antidepressant, Induces Apoptosis in Hepatic Cells Through the Mitogen-Activated Protein Kinase Pathway journal November 2013
Mechanistic Evaluation of Ginkgo biloba Leaf Extract-Induced Genotoxicity in L5178Y Cells journal March 2014
Pharmacogenetics and herb???drug interactions: experience with Ginkgo biloba and omeprazole journal January 2004
DNA Topoisomerases: Structure, Function, and Mechanism journal June 2001
Usefulness of Monitoring γ-H2AX and Cell Cycle Arrest in HepG2 Cells for Estimating Genotoxicity Using a High-Content Analysis System journal June 2014
Pharmaceutical quality of different Ginkgo biloba brands journal May 2002
Stabilization of Eukaryotic Topoisomerase II-DNA Cleavage Complexes journal January 2003
Mutagenicity of Flavonoids Assayed by Bacterial Reverse Mutation (Ames) Test journal May 2012
Topoisomerase II enzymes and mutagenicity journal January 1994
Efficacy and safety of Ginkgo biloba extract EGb 761 ® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind, multi‐center trial journal March 2014
Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry: Quantitation of components in Ginkgo biloba extract by LC/MS journal August 2006
The GADD45a-GFP GreenScreen HC Assay book December 2011
Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group journal November 1996
Genotoxicity of quercetin in the micronucleus assay in mouse bone marrow erythrocytes, human lymphocytes, V79 cell line and identification of kinetochore-containing (CREST staining) micronuclei in human lymphocytes journal June 1995
Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens journal May 1998
Catalytic topoisomerase II inhibitors in cancer therapy journal August 2003
Genotoxicity of several clinically used topoisomerase II inhibitors journal July 2000
Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology journal June 2001
Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial journal October 2012
Chk1 and Chk2 kinases in checkpoint control and cancer journal May 2003
The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells journal February 2010
Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives journal December 1992
All tangled up: how cells direct, manage and exploit topoisomerase function journal November 2011
Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity journal December 2004
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia journal April 2000
Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans1 journal September 2008
Topoisomerase II and leukemia: Topoisomerase II and leukemia journal February 2014
Effects of Ginkgo Biloba Extract on Pharmacokinetics and Pharmacodynamics of Tolbutamide and Midazolam in Healthy Volunteers journal November 2006
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial journal September 2012
EGb 761 journal January 2003
Flavonoids Acting on DNA Topoisomerases: Recent Advances and Future Perspectives in Cancer Therapy journal November 2012

Cited By (6)

Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification journal May 2016
Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells journal November 2019
The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation journal August 2018
MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells journal December 2018
Review of Ginkgo biloba -induced toxicity, from experimental studies to human case reports journal January 2017
Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells journal January 2018

Similar Records

Mechanism study of goldenseal-associated DNA damage
Journal Article · Tue Jun 04 20:00:00 EDT 2013 · Toxicology Letters · OSTI ID:1905029

Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: Identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1
Journal Article · Mon May 15 00:00:00 EDT 2006 · Toxicology and Applied Pharmacology · OSTI ID:20783475

Interrogation of spatial metabolome of Ginkgo biloba with high‐resolution matrix‐assisted laser desorption/ionization and laser desorption/ionization mass spectrometry imaging
Journal Article · Mon Aug 06 20:00:00 EDT 2018 · Plant, Cell and Environment · OSTI ID:1463202